FIELD: experimental medicine and oncology.
SUBSTANCE: claimed method includes intraperitoneum cyclophosphan administration in dose of 120 mg/kg and intravenous transplantation of fetal liver steam cells to experimental animal. Fetal liver steam cells are transplanted for 3 days before cyclophosphan administration in dose of 25x106 cells/kg of mass.
EFFECT: decreased tumor growth, reduced frequency and area of metastasis due to optimization of cyclophosphan and steam cells administration.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION INCREASING ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF CYCLOPHOSPHAN | 2002 |
|
RU2225720C1 |
| AGENTS IMPROVING ANTICANCER AND ANTIMETASTATIC ACTIVITY OF CYTOSTATICS | 2011 |
|
RU2471496C1 |
| MEANS FOR ANTIMETASTATIC ACTIVITY AND IMPROVED ANTIMETASTATIC ACTION OF CYCLOPHOSPHANE | 2016 |
|
RU2657602C1 |
| METHOD FOR CREATING BIOLOGICAL MODEL OF MODERATE GROWTH INHIBITION OF TUMOUR AND METASTASES IN LEWIS LUNG CARCINOMA WITH PROLONGED CYCLOPHOSPHANINE-INDUCED LEUKOPENIA IN MICE | 2012 |
|
RU2488173C1 |
| AGENT BASED ON POLYSACCHARIDES FROM CALAMUS ROOT ENHANCING OF ANTI-TUMOR AND ANTI-METASTASIS ACTIVITY OF CYTOSTATIC PREPARATIONS | 2005 |
|
RU2308285C2 |
| AGENT INCREASING ANTI-METASTATIC ACTIVITY OF CYCLOPHOSPHAN | 2016 |
|
RU2613189C1 |
| AGENT WITH ANTITUMOR AND ANTIMETASTATIC ACTIVITY, INCREASING ANTIMETASTATIC EFFECT OF CYCLOPHOSPHAN | 2015 |
|
RU2578457C1 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| CORRECTOR OF CYTOSTATIC POLYCHEMOTHERAPY | 2007 |
|
RU2353623C1 |
| CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
